Intertek — Stability Studies for Biopharmaceuticals

September 29, 2009

Timely and accurate evaluation of identity, strength, quality, purity and potency are key to successfully managing stability and release programs.

Timely and accurate evaluation of identity, strength, quality, purity and potency are key to successfully managing stability and release programs. With pharmaceutical stability storage capabilities in UK and Ireland, integrated with GMP analytical capabilities, Intertek scientists can design, initiate and conduct all aspects of your stability and batch release studies with specialist capabilities for biopharmaceuticals. Intertek stability studies for protein therapeutics, for example, can involve a range of technologies including; peptide fingerprinting / sequencing by LC-MS/MS, SDS-PAGE, IEF, amino acid analysis, CE, glycan analysis and more.

Intertek will be exhibiting at ICSE, Madrid in Oct 2009. Please Visit stand 8BIO40 to find out more

www.intertek.com/pharmaceutical